دورية أكاديمية
أعرض في EDS

Can polyphenols improve the gut health status in pre-clinical study with diet-induced obesity?: A protocol for systematic review and/or meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Can polyphenols improve the gut health status in pre-clinical study with diet-induced obesity?: A protocol for systematic review and/or meta-analysis.
المؤلفون: Dias LKM; Nutrition Postgraduate Program, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Brazil., de Medeiros GCBS; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil., Silva AKN; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil., de Araujo Morais AH; Nutrition Postgraduate Program, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Brazil.; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.; Biochemistry and Molecular Biology Postgraduate Program, Center for Biosciences, Federal University of Rio Grande do Norte, Natal, Brazil., da Silva-Maia JK; Nutrition Postgraduate Program, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Brazil.; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
المصدر: Medicine [Medicine (Baltimore)] 2021 Dec 10; Vol. 100 (49), pp. e28162.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Obesity*, Gastrointestinal Microbiome/*drug effects , Polyphenols/*pharmacology, Animals ; Diet ; Health Status ; Meta-Analysis as Topic ; Mice ; Polyphenols/therapeutic use ; Rats
مستخلص: Introduction: Obesity is characterized as a low-grade inflammation that impairs physiological functions, including intestinal functioning and gut microbiota balance. Dietary polyphenols can be a strategy for obesity management, collaborating to preserve or recover gut health through antioxidant and anti-inflammatory actions, as well as modulators of the microbiota. This study describes a systematic review protocol to elucidate effects of polyphenols on intestinal health of pre-clinical models with diet-induced obesity. AIM: Our aim is to evaluate evidence about polyphenols' effects in the gut microbiota composition and diversity, parameters of the physical and molecular status of the gut barrier in obese models, additionally, understand the possible involved mechanisms.
Methodology: A protocol was developed and published on PROSPERO (Registration No: CRD42021262445). Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols is used to outline the protocol. The articles will be selected according to the PICOS strategy (population, interventions, control, outcome, and study design) in the following databases: PubMed, Science Direct, Scopus, Web of Science, and EMBASE. Experimental studies performed on rats and mice with a control group that describes treatment with polyphenols (from food matrix or crude extracts or isolated compounds) at any frequency, time, and dose will be included. Two reviewers will, independently, select the papers, extract data, and evaluate the data quality. The Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) tool will be used to assess the risk of bias.
Expected Results: Results will be showed through of native synthesis and, if possible, a metanalysis will be conducted. The review produced with this protocol can show the scientific evidence level about polyphenols' effects in intestinal health in obesity status.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: Oliveira CBC, de, Brito LA, et al. Obesity: inflammation and bioactive compounds Carla. J Heal Biol Sci 2020;8:01.
Lyu X, Lee J, Chen WN. Potential natural food preservatives and their sustainable production in yeast: terpenoids and polyphenols. Published online 2019;doi:10.1021/acs.jafc.8b07141. (PMID: 10.1021/acs.jafc.8b07141)
Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 2013;24:1415–22.
Bernardi S, Bo C, Del, Marino M, et al. Polyphenols and intestinal permeability: rationale and future perspectives. J Agric Food Chem 2020;doi:10.1021/acs.jafc.9b02283. (PMID: 10.1021/acs.jafc.9b02283)
Zhao Y, Chen B, Shen J, et al. The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxid Med Cell Longev 2017;2017:1459497.
Novotny JA, Chen TY, Terekhov AI, et al. The effect of obesity and repeated exposure on pharmacokinetic response to grape polyphenols in humans. Mol Nutr Food Res 2017;61:01–6.
Zhang N-N, Guo W-H, Hu H, et al. Effect of a polyphenol-rich canarium album extract on the composition of the gut microbiota of mice fed a high-fat diet. Molecules 2018;23:09.
World Health Organization (WHO). Obesity and overweight. World Health Organization (WHO). 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight . Accessed in November 2021.
Fitria O. Transplante Fecal E Sua Possível Aplicação No Tratamento Da Obesidade: Uma Revisão De Literatura the. J Chem Inf Model 2013;53:1689–99.
Muscogiuri G, Cantone E, Cassarano S, et al. Gut microbiota: a new path to treat obesity. Int J Obes Suppl 2019;9:10–9.
Sun L, Ma L, Ma Y, Zhang F, Zhao C, Nie Y. Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell 2018;9:397–403.
Aron-wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery Published online 2019;70–82. doi:10.1136/gutjnl-2018-316103. (PMID: 10.1136/gutjnl-2018-316103)
Liu J, He Z, Ma N, Chen ZY. Beneficial effects of dietary polyphenols on high-fat diet-induced obesity linking with modulation of gut microbiota. J Agric Food Chem 2020;68:33–47.
Alves BKR, Santos LC, Dos SOUSA PVDL, Santos GM, Dos Barros NVDA. Prevalência de Sinais e Sintomas Sugestivos de Disbiose Intestinal em Acadêmicos de Uma Instituição de Ensino Superior. Rev Bras Obesidade Nutr e Emagrecimento 2020;14:588–97.
Alves-santos AM, Sandra C, Sugizaki A, Lima GC. Prebiotic effect of dietary polyphenols: a systematic review. J Funct Foods 2020;74(September):104169.
Verediano TA, Stampini Duarte Martino H, Dias Paes MC, Tako E. Effects of anthocyanin on intestinal health: a systematic review. Nutrients 2021;13:04.
Peron G, Hidalgo-Liberona N, González-Domínguez R, et al. Exploring the molecular pathways behind the effects of nutrients and dietary polyphenols on gut microbiota and intestinal permeability: a perspective on the potential of metabolomics and future clinical applications. J Agric Food Chem 2020;68:1780–9.
Bernardi L, Malinoski B, Cain JP, Antonovicz S. Amaral LA do. Experimental models for studies in nutrition: hypertension and diabetes mellitus. Visão Acadêmica 2017;17:69–87.
Guirro M, Costa A, Gual-Grau A, et al. Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: a multiomics approach. PLoS One 2019;14:01–19.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1177–85.
Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372.
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: Elaboration and explanation. BMJ 2015;349(January):01–25.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016;5:01–10.
Zaugg H, West RE, Tateishi I, Randall DL. Mendeley: creating communities of scholarly inquiry through research collaboration. TechTrends 2011;55:32–6.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 2021;18:01–15.
Sandoval-Ramírez BA, Catalán Ú, Pedret A, et al. Exploring the effects of phenolic compounds to reduce intestinal damage and improve the intestinal barrier integrity: a systematic review of in vivo animal studies. Clin Nutr 2021;40:1719–32.
Nash V, Ranadheera CS, Georgousopoulou EN, et al. The effects of grape and red wine polyphenols on gut microbiota: a systematic review. Food Res Int 2018;113:277–87.
Koch W. Dietary polyphenols—important non-nutrients in the prevention of chronic noncommunicable diseases. A systematic review. Nutrition 2019;11:05.
Gomes JVP, Rigolon TCB, Souza MS, da S, et al. Antiobesity effects of anthocyanins on mitochondrial biogenesis, inflammation, and oxidative stress: a systematic review. Nutrition 2019;66:192–202.
Ballard RC, Galvão FT, Cazarin BBC, Maróstica RM. Effects of polyphenol-rich fruit extracts on diet-induced obesity in rodents: systematic review and meta-analysis. Curr Pharm Des 2019;25:3484–97.
DeWeerdt S. Microbiome: a complicated relationship status. Nature 2014;508: (7496 SUPPL): 08–10.
Li H, Lelliott C, Håkansson P, et al. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism 2008;57:1704–10.
CastaNer O, Godaya, Park Y-M, et al. Response to: comment on “The Gut Microbiome Profile in Obesity: A Systematic Review”. Int J Endocrinol 2018;2018:01–9.
Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes 2018;9:308–25.
Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 2016;8:01–12.
Covasa M. Gut microbiota modulates intestinal signalling in obesity. Appetite 2016;96:643.
Tavares S, Araújo C, Bressan J. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutrición Hospitalaria 2013;28:1039–48.
Fazel S, Luigi G, Daglia M, Mohammad S. Role of quercetin as an alternative for obesity treatment: You are what you eat!. FOOD Chem 2015;179:305–10.
Carpéné C, Gomez-zorita S, Deleruyelle S, Carpéné MA. Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Curr Medicinal Chem 2015;150–64.
Bruno RS, Neilson AP, Lambert JD, Moustaid-Moussa N. Journal of Nutritional Biochemistry Special Issue: Polyphenols, obesity, and cardiometabolic health. J Nutr Biochem 2021;89:2020–2. doi:10.1016/j.jnutbio.2020.108565. (PMID: 10.1016/j.jnutbio.2020.108565)
Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev 2018;39:79–132.
Tomás-Barberán FA, Andrés-Lacueva C. Polyphenols and health: current state and progress. J Agric Food Chem 2012;60:8773–5.
Corrêa TA, Rogero MM. Polyphenols regulating microRNAs and inflammation biomarkers in obesity. Nutrition 2019;59:150–7.
Gerardi G, Cavia-Saiz M, Rivero-Pérez MD, González-SanJosé ML, Muñiz P. Wine pomace product modulates oxidative stress and microbiota in obesity high-fat diet-fed rats. J Funct Foods 2020;68(March):01–10.
Lee S, Keirsey KI, Kirkland R, Grunewald ZI, Fischer JG, de La Serre CB. Blueberry supplementation influences the gut microbiota, inflammation, and insulin resistance in high-fat-diet-fed rats. J Nutr 2018;148:209–19.
معلومات مُعتمدة: 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
المشرفين على المادة: 0 (Polyphenols)
تواريخ الأحداث: Date Created: 20211210 Date Completed: 20220207 Latest Revision: 20230927
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8663835
DOI: 10.1097/MD.0000000000028162
PMID: 34889285
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000028162